About
RenalSense is a medical device company focused on real-time renal diagnostics. Their flagship product, Clarity RMS, provides continuous, automated urine output monitoring in critical care settings, enabling early detection of acute kidney injury (AKI) and guiding fluid management decisions for improved patient outcomes.
Key facts
At-a-glance profile data
- Website
- renalsense.com
- Headquarters
- Netanya, Israel
- Founded
- 2009
- Employees
- 7
- Total funding
- $34M (Series A)
- Business model
- B2B
Funding rounds
Tech stack
Detected on renalsense.com, last scanned 16 Jul 2026. Run your own scan
- Hosting
- Google Cloud
- Email provider
- Microsoft 365
āCHFS partnership announced this morning. They also voted for NO REVERSE SPLIT after not completing there canceled meeting June 19th. With the webinar tomorrow hope to expect a continued run up until tomorrow morning.ā
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
Frequently asked
How much funding has RenalSense raised?
RenalSense has raised a total of $34M in funding. The most recent round on record is Series A.
How many employees does RenalSense have?
RenalSense has approximately 7 people on record.
What is RenalSense's current status?
RenalSense's current operating status is: Inactive.